D. Demets, Clinical trials in the new millennium, Statistics in Medicine, vol.52, issue.19, pp.2779-8727, 2002.
DOI : 10.7326/0003-4819-125-7-199610010-00011

J. Jakobsen and C. Gluud, The Necessity of Randomized Clinical Trials, British Journal of Medicine and Medical Research, vol.3, issue.4, pp.453-1468, 2013.
DOI : 10.9734/BJMMR/2013/3208

S. Garattini, J. Jakobsen, J. Wetterslev, V. Bertele, R. Banzi et al., Evidence-based clinical practice: Overview of threats to the validity of evidence and how to minimise them, European Journal of Internal Medicine, vol.32, pp.13-21, 2016.
DOI : 10.1016/j.ejim.2016.03.020

L. Duley, K. Antman, J. Arena, A. Avezum, M. Blumenthal et al., Specific barriers to the conduct of randomized trials, Clinical Trials, vol.334, issue.3, pp.40-48, 2008.
DOI : 10.1136/bmj.39140.623137.BE

J. Demotes-mainard and C. Kubiak, A European perspective - the European clinical research infrastructures network, Annals of Oncology, vol.22, issue.Suppl 7, pp.44-911, 2011.
DOI : 10.1093/annonc/mdr425

J. Adams, Collaborations: The rise of research networks, Nature, vol.23, issue.7420, pp.335-341, 2012.
DOI : 10.1038/4501165a

S. Glickman, J. Mchutchison, E. Peterson, C. Cairns, R. Harrington et al., Ethical and Scientific Implications of the Globalization of Clinical Research, New England Journal of Medicine, vol.360, issue.8, pp.816-839, 2009.
DOI : 10.1056/NEJMsb0803929

I. Atal, L. Trinquart, R. Porcher, and P. Ravaud, Differential globalization of industryand non-industry-sponsored clinical trials, PLoS One, vol.10, issue.12, pp.145122-2015, 2015.
DOI : 10.1371/journal.pone.0145122
URL : http://doi.org/10.1371/journal.pone.0145122

A. Rath, V. Salamon, S. Peixoto, V. Hivert, M. Laville et al., Evidencebased clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be removed? Trials

E. Neugebauer, A. Rath, S. Antoine, M. Eikermann, D. Seidel et al., Specific barriers to the conduct of randomised clinical trials on medical devices-the European Clinical Research Infrastructure Network (ECRIN) perspective. Trials

M. Laville, B. Segrestin, Y. Masson, C. Ruano-rodríguez, L. Serra-majem et al., Evidence-based practice within nutrition: what are the obstacles for improving the evidence and how can they be dealt with? Trials

R. Oliveri, C. Gluud, and P. Wille-jorgensen, Hospital doctors??? self-rated skills in and use of evidence-based medicine - a questionnaire survey, Journal of Evaluation in Clinical Practice, vol.324, issue.2, pp.219-245, 2004.
DOI : 10.1136/bmj.324.7343.950

L. Ulvenes, O. Aasland, M. Nylenna, and I. Kristiansen, Norwegian Physicians' Knowledge of and Opinions about Evidence-Based Medicine: Cross-Sectional Study, PLoS ONE, vol.30, issue.11, p.7828, 2009.
DOI : 10.1371/journal.pone.0007828.t003
URL : http://doi.org/10.1371/journal.pone.0007828

I. Chalmers and P. Glasziou, Avoidable waste in the production and reporting of research evidence, Lancet, vol.37416, issue.968306, pp.86-95, 2009.

P. Glasziou, D. Altman, P. Bossuyt, I. Boutron, M. Clarke et al., Reducing waste from incomplete or unusable reports of biomedical research, The Lancet, vol.383, issue.9913, pp.267-76, 2014.
DOI : 10.1016/S0140-6736(13)62228-X

A. Chan, F. Song, A. Vickers, T. Jefferson, K. Dickersin et al., Increasing value and reducing waste: addressing inaccessible research, The Lancet, vol.383, issue.9913, pp.257-66, 2014.
DOI : 10.1016/S0140-6736(13)62296-5
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533904

A. Salman, R. Beller, E. Kagan, J. Hemminki, E. Phillips et al., Increasing value and reducing waste in biomedical research regulation and management, The Lancet, vol.383, issue.9912, pp.176-85, 2014.
DOI : 10.1016/S0140-6736(13)62297-7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952153

J. Ioannidis, S. Greenland, M. Hlatky, M. Khoury, M. Macleod et al., Increasing value and reducing waste in research design, conduct, and analysis, The Lancet, vol.383, issue.9912, pp.166-75, 2014.
DOI : 10.1016/S0140-6736(13)62227-8
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697939

I. Chalmers, M. Bracken, B. Djulbegovic, S. Garattini, J. Grant et al., How to increase value and reduce waste when research priorities are set, The Lancet, vol.383, issue.9912, pp.156-65, 2014.
DOI : 10.1016/S0140-6736(13)62229-1

D. Moher, P. Glasziou, I. Chalmers, M. Nasser, P. Bossuyt et al., Increasing value and reducing waste in biomedical research: who's listening?, The Lancet, vol.387, issue.10027, p.2, 2015.
DOI : 10.1016/S0140-6736(15)00307-4

T. Chalmers, Randomize the first patient, N Engl J Med. Epub, vol.29613, issue.201, p.107, 1977.

J. Higgins and S. Green, The Cochrane Handbook for Systematic Reviews of Interventions, 2011.
DOI : 10.1002/9780470712184

G. Guyatt, A. Oxman, S. Sultan, J. Brozek, P. Glasziou et al., GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes, Journal of Clinical Epidemiology, vol.66, issue.2, pp.151-158, 2013.
DOI : 10.1016/j.jclinepi.2012.01.006

J. Deeks, J. Dinnes, D. Amico, R. Sowden, A. Sakarovitch et al., Evaluating non-randomised intervention studies, Health Technology Assessment, vol.7, issue.27, pp.1-173, 2003.
DOI : 10.3310/hta7270
URL : https://njl-admin.nihr.ac.uk/document/download/2004687

J. Ioannidis, Why most published research findings are false, PLoS Med. Epub, vol.2, issue.8, p.12403, 2005.

J. Ioannidis, A. Haidich, M. Pappa, N. Pantazis, S. Kokori et al., Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies, JAMA, vol.286, issue.7, pp.821-851, 2001.
DOI : 10.1001/jama.286.7.821

V. Berger, What do non-randomized trials offer above and beyond randomized trials?, Contemporary Clinical Trials, vol.35, issue.1, pp.168-177, 2013.
DOI : 10.1016/j.cct.2013.03.008

A. Pares, L. Caballeria, and J. Rodes, Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid, Gastroenterology, vol.130, issue.3, pp.715-2015, 2006.
DOI : 10.1053/j.gastro.2005.12.029

W. Lammers, H. Van-buuren, G. Hirschfield, H. Janssen, P. Invernizzi et al., Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study, Gastroenterology, vol.147, issue.6, pp.1338-1387, 2014.
DOI : 10.1053/j.gastro.2014.08.029

C. Gluud and E. Christensen, Ursodeoxycholic acid for primary biliary cirrhosis, Cochrane Database Syst Rev. Epub, vol.30, issue.Suppl 1, p.55101, 2002.
DOI : 10.1016/S0168-8278(01)81676-7

Y. Gong, Z. Huang, E. Christensen, and C. Gluud, Ursodeoxycholic acid for primary biliary cirrhosis, Cochrane Database Syst Rev, vol.30, issue.4, p.55105, 2008.
DOI : 10.1002/14651858.CD000551

J. Rudic, G. Poropat, M. Krstic, G. Bjelakovic, and C. Gluud, Ursodeoxycholic acid for primary biliary cirrhosis, Cochrane Database Syst Rev, vol.16, issue.3, p.551, 2012.
DOI : 10.1002/14651858.CD000551

P. Winkel, J. Hilden, J. Hansen, J. Kastrup, H. Kolmos et al., Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial, International Journal of Cardiology, vol.182, pp.459-65, 2015.
DOI : 10.1016/j.ijcard.2015.01.020

P. Winkel and N. Zhang, Statistical development of quality in medicine, pp.1-280, 2007.
DOI : 10.1002/9780470515884

A. Briggs, Economic evaluation and clinical trials: size matters, BMJ, vol.321, issue.7273, pp.1362-1365, 2000.
DOI : 10.1136/bmj.321.7273.1362

F. Bourgeois, S. Murthy, and K. Mandl, Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov, Annals of Internal Medicine, vol.153, issue.3, pp.158-66, 2010.
DOI : 10.7326/0003-4819-153-3-201008030-00006
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374868/pdf

M. Neyt, T. Christiaens, J. Demotes, T. Walley, and F. Hulstaert, Publicly funded practice-oriented clinical trials: of importance for healthcare payers, Journal of Comparative Effectiveness Research, vol.5, issue.6, pp.551-60, 2016.
DOI : 10.2217/cer-2016-0018

G. Forum and H. Research, The 10/90 report on health research Global Forum for Health Research Available from, 2000.

Z. Bhutta, Ethics in international health research: a perspective from the developing world, Bull World Health Organ, vol.8016, issue.2, pp.114-134, 2002.

E. Commission, Horizon 2020 in brief. The EU Framework Programme for Research & Innovation. Directorate-General for Research and Innovation, p.2014, 2017.

E. Commission and . Horizon, First results. Directorate-General for Research and Innovation Available from: https, p.2015, 2017.

C. Reith, M. Landray, P. Devereaux, J. Bosch, C. Granger et al., Randomized Clinical Trials ??? Removing Unnecessary Obstacles, New England Journal of Medicine, vol.369, issue.11, pp.1061-1066, 2013.
DOI : 10.1056/NEJMsb1300760

B. Morrison, C. Cochran, J. White, J. Harley, C. Kleppinger et al., Monitoring the quality of conduct of clinical trials: a survey of current practices, Clinical Trials, vol.44, issue.3, pp.342-351, 2011.
DOI : 10.1016/j.ahj.2004.04.049

D. Grimes, D. Hubacher, K. Nanda, K. Schulz, D. Moher et al., The Good Clinical Practice guideline: a bronze standard for clinical research, The Lancet, vol.366, issue.9480, pp.172-176, 2005.
DOI : 10.1016/S0140-6736(05)66875-4

E. Eisenstein, R. Collins, B. Cracknell, O. Podesta, E. Reid et al., Sensible approaches for reducing clinical trial costs, Clinical Trials, vol.357, issue.1, pp.75-84, 2008.
DOI : 10.1056/NEJMoa065994

I. Agaku, A. Adisa, O. Ayo-yusuf, and G. Connolly, Concern about security and privacy, and perceived control over collection and use of health information are related to withholding of health information from healthcare providers, Journal of the American Medical Informatics Association, vol.21, issue.2, pp.374-808, 2013.
DOI : 10.1136/amiajnl-2013-002079

M. Skoog, J. Saarimäki, C. Gluud, M. Sheinin, K. Erlendsson et al., Transparency and registration in clinical research in the Nordic countries. NordForsk: Nordic Trial Alliance, pp.1-108, 2015.

S. Killeen, P. Sourallous, I. Hunter, J. Hartley, and H. Grady, Registration Rates, Adequacy of Registration, and a Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials Published in Surgery Journals, Annals of Surgery, vol.259, issue.1, pp.193-199, 2014.
DOI : 10.1097/SLA.0b013e318299d00b

J. Ross, T. Tse, D. Zarin, H. Xu, L. Zhou et al., Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis, BMJ, vol.344, issue.jan03 1, p.7292, 2012.
DOI : 10.1136/bmj.d7292

C. Gluud, C. Kubiak, K. Whitfield, J. Byrne, K. Huemer et al., Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries, Trials, vol.6, issue.1, p.27, 2012.
DOI : 10.1177/1740774509347398
URL : https://hal.archives-ouvertes.fr/inserm-00692048

M. Hartmann, Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries, Trials, vol.49, issue.1, p.53, 2012.
DOI : 10.1177/0091270008329557

M. Hartmann and F. Hartmann-vareilles, The Clinical Trials Directive: How Is It Affecting Europe's Noncommercial Research, PLoS Clinical Trials, vol.11, issue.2, p.13, 2006.
DOI : 10.1371/journal.pctr.0010013.t001
URL : http://doi.org/10.1371/journal.pctr.0010013

A. European-medicines, Clinical Trial Regulation Available from, p.2017, 2017.

D. Cressey, Overhaul complete for EU clinical trials, Nature
DOI : 10.1038/nature.2014.15339

R. Hernandez, M. Cooney, C. Duale, M. Galvez, S. Gaynor et al., Harmonisation of ethics committees' practice in 10 European countries, Journal of Medical Ethics, vol.35, issue.11, pp.696-700, 2009.
DOI : 10.1136/jme.2009.030551

N. Fost and R. Levine, The Dysregulation of Human Subjects Research, JAMA, vol.298, issue.18, pp.2196-2204, 2007.
DOI : 10.1001/jama.298.18.2196

R. Sherman, J. Woodcock, J. Norden, C. Grandinetti, and R. Temple, New FDA Regulation to Improve Safety Reporting in Clinical Trials, New England Journal of Medicine, vol.365, issue.1, pp.3-5, 2011.
DOI : 10.1056/NEJMp1103464

M. Gehring, R. Taylor, M. Mellody, B. Casteels, A. Piazzi et al., Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study), BMJ Open, vol.3, issue.11, p.2957, 2013.
DOI : 10.1136/bmjopen-2013-002957

J. Boeynaems, C. Canivet, A. Chan, M. Clarke, C. Cornu et al., A European approach to clinical investigator training, Frontiers in Pharmacology, vol.4, p.112, 2013.
DOI : 10.3389/fphar.2013.00112
URL : http://doi.org/10.3389/fphar.2013.00112

S. Chakradhar, In new crowdfunding trend, donors decide fate of clinical trials, Nature Medicine, vol.21, issue.2, pp.101-103, 2015.
DOI : 10.1038/nm0215-101

A. Sharma, J. Khan, and P. Devereaux, Is crowdfunding a viable source of clinical trial research funding?, The Lancet, vol.386, issue.9991, p.338, 2015.
DOI : 10.1016/S0140-6736(15)61407-6

K. Oba, Statistical challenges for central monitoring in clinical trials: a review, International Journal of Clinical Oncology, vol.15, issue.1
DOI : 10.1007/s10120-015-0533-9

A. European-medicines, Reflection paper on risk based quality management in clinical trials, 2011.

D. Food and . U. Administration, Department of Health and Human Services Guidance for Industry: Oversight of clinical investigations, a risk based approach to monitoring, p.2013

A. Lundh, J. Lexchin, B. Mintzes, J. Schroll, and L. Bero, Industry sponsorship and research outcome, Cochrane Database Syst Rev, issue.2, 2017.

R. Prescott, C. Counsell, W. Gillespie, A. Grant, I. Russell et al., Factors that limit the quality, number and progress of randomised controlled trials, Health Technol Assess, vol.3, issue.20, p.139, 1999.

D. Hsiehchen, M. Espinoza, and A. Hsieh, The Cooperative Landscape of Multinational Clinical Trials, PLOS ONE, vol.506, issue.7487, p.130930, 2015.
DOI : 10.1371/journal.pone.0130930.g008

J. Adams, Collaborations: The fourth age of research, Nature, vol.34, issue.7451, pp.557-6031, 2013.
DOI : 10.1016/j.respol.2005.01.014